Impact Factor
4.01
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.10
3,577 total citations
h5-index
61
h5 depth signal
Cited share
76.7%
705 of 919
Total citations
3,577
Citation footprint
Metric signal
3.53
External metric anchor
Self-citation
3.9%
139 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,028
Italy
1,013
Germany
842
France
753
United Kingdom
613
Citing Fields of Research
Hematology
3,499
Lymphomas
1,527
Immunology
785
Oncology
327
Cancer & Development
215
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,706
Articles tracked across the journal lifetime
Indexed publication set
919
705 cited publications
Last 12 months
944
78.7 publications/month
Open access share
99.9%
943 OA publications in the last year
Leading citing country
United States
2,028 citing publications
Leading citing field
Hematology
3,499 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v50n3, 1965-
v50n3, 1965-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Lymphomas
Broad Categories
Hematology
Lymphomas
MeSH Descriptors
Hematology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3324/haematol.2026.302048
Open DOI
The double-edged sword of Plasmodium falciparum: malaria and a predisposition to B-cell malignancy?
02
03
DOI 10.3324/haematol.2026.302108
Open DOI
Beyond exclusion: the case for genetic screening in immune thrombocytopenia
04
DOI 10.3324/haematol.2026.302137
Open DOI
Response to Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”
05
DOI 10.3324/haematol.2026.300846
Open DOI
Early measurement of ST2 and REG3α has a prognostic impact in haploidentical transplantation with post-transplant cyclophosphamide
Research on predictive biomarkers in haploidentical SCT (haplo-HSCT) with post-transplant cyclophosphamide (PTCy) remains limited, particularly regarding the critical first week post-infusion. We prospectively evaluated serum ST2, REG3α,...
06
07
08
DOI 10.3324/haematol.2026.301327
Open DOI
Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expression
CAR NK cell therapy is expected to be developed to treat acute myeloid leukemia (AML). C-type lectin-like molecule 1 (CLL-1) is a candidate target. However, AML cells with minimal CLL-1 expression (CLL-1dim) may not be eliminated by CAR ...
09
10
Bibliographical & Catalog Notes
Issues for <Dec. 1998-> called also: Journal of hematology.
Online version called also: Haematologica on Internet.
Issues for Jan. 2005- have subtitle: Hematology journal.
Issued 1930-33 in two parts: I. Archivio and II. Rencensioni. Rencensioni catalogued separately in this library.
Latest issue consulted: surrogate of Vol. 84, no. 1 (Jan. 1999).
Vol. numbers irregular: v. 21 omitted.
Supplements accompany some numbers.
In addition to the regular monthly issue, Vol. 84, no. 6 (June 1999), there were two supplements also issued in June 1999: a supplement of meeting abstracts (called Abstr Suppl at NLM) and supplement EHA-4, Education book.
Also issued online.
Microfilm. v. 1 (1920)-31 (1948). 22 microfilm reels : negative ; 35 mm.
Summaries in English, French, and German.
Vols. for <1999-> called International ed. and have all articles in English.
Published also in a Spanish ed. by Ediciones Doyma, which includes all of the content of the International ed., plus selected abstracts in Spanish, 1997-